<DOC>
	<DOCNO>NCT00265070</DOCNO>
	<brief_summary>This study carry see ZD1839 effective treat prostate cancer diagnose early rising PSA ( prostate specific antigen ) follow surgery .</brief_summary>
	<brief_title>Trial Iressa Prostate Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Removal prostate prostate cancer Raised level prostate specific antigen ( PSA ) postsurgery Can receive radiation therapy Any surgery male hormone block therapy . Low white blood cell count Abnormal liver function test</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>